Phillips-Medisize announced a 60,000-sq-ft expansion to their Kontiolahti, Finland, site. This site focuses on the production of complex drug delivery devices such as inhalers, injection pens and safety syringes. This state-of-the art facility manufactures products from multi component drug delivery devices in prototype form to finished drug delivery devices in a high-speed automated production environment. At this year’s MEDTEC Europe, running 26 to 28 February in Stuttgart, Germany, the company will also be exhibiting its contract development and manufacturing capabilities for medical, diagnostic and drug delivery devices, including product development & design, engineering, in-house tool making, moulding, welding, high-speed automated assembly, packaging and sterilisation.
The company’s latest expansion was driven by new opportunities that Phillips-Medisize has been awarded over the past 12 months, as well as to support increased global demand for devices with precise dosage drug delivery requirements, which the company currently manufactures at the Kontiolahti site. This expansion is meant to increase moulding and assembly capabilities at the site. Staffing will also be increased by over 15% during the next two years. Today, 336 professionals are focused on meeting the needs of drug delivery device customers around the world. The combination of a stable and experienced medical work force, extensive in-house tool making, state-of- the-art metrology, modern cleanrooms, injection moulding and high-volume automated assembly capabilities underlines the company’s mission to provide leading edge technologies and facilities to support OEM customers.
Commenting on this plant expansion, Matt Jennings, President and CEO of Phillips-Medisize Corporation, said, “This plant expansion is in keeping with our global strategy of offering design and development services and associated manufacturing processes for our medical customers. We support this strategy by investing in our people, processes and facilities to assure we can meet the quality, service and performance expectations of our customers. Although a portion of this new capacity will be taken up by recent wins, we did also plan for future customer growth requirements in this expansion.”
Visit Phillips-Medisize during MEDTEC Europe at stand 1M26.Yvonne Klöpping